CME credits: 0.25

Valid until: 31-12-2020

Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/viewpoints-on-managing-dr-dme-implementing-the-latest-treatment-strategies/10903/

Even though diabetic retinopathy is the leading cause of blindness in adults, it’s important to remember that effective treatments are available. Here to review when patients with suspected diabetic retinopathy and diabetic macular edema should be considered for therapeutic interventions to prevent vision loss are Dr. Sharon Solomon and Dr. Diana Do.

Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.